Ambarella Inc.
AMBA
$66.50
+5.35%
Ambarella, Inc. is a fabless semiconductor company that designs low-power system-on-a-chip (SoC) processors and accompanying software for edge and physical artificial intelligence applications, spanning video security cameras, automotive camera and ADAS systems, autonomous mobile robots, industrial automation, intelligent transportation, and consumer devices such as action, drone, and 360-degree cameras. With roughly 380 employees and a market capitalization near $3 billion, Ambarella operates as a focused, high-value niche player rather than a broad-line chipmaker, competing on power efficiency and computer-vision performance in embedded vision markets dominated by larger rivals. The current investor narrative centers on the company's pivot from legacy consumer action-camera silicon toward edge AI and automotive computer vision, a transition that has produced double-digit revenue growth and a string of quarterly beats but has yet to deliver sustained GAAP profitability. Recent headlines highlight Q2 earnings and revenue surpassing estimates and a high-profile $120 price target tied to the edge AI story, yet the stock has sharply underperformed the market over the past year, leaving investors debating whether the AI-driven re-rating is a durable inflection or an expensive bet on a still-unprofitable growth story.…
AMBA
Ambarella Inc.
$66.50
Related headlines
Investment Opinion: Should I buy AMBA Today?
Rating: Hold. Ambarella offers a compelling edge AI growth story with 44.8% upside to the average analyst target of $89.36, but the lack of profitability and premium valuation warrant a cautious stance until there is clearer evidence of operating leverage. The consensus leans bullish with 11 analysts covering and a $120 high target, but the wide dispersion and the stock's 26.6% one-year decline suggest the market is not yet convinced.
The supporting evidence is mixed: revenue grew 13.2% year-over-year to $108.1 million, gross margin is stable at 57.7%, and the balance sheet is debt-free with $102.3 million in cash. However, the company remains unprofitable with a -19.4% net margin and negative free cash flow, and the 7.0x PS multiple is a premium for a company growing at 13.2%. The PEG ratio of 0.96 is attractive only if forward EPS estimates of $4.35 are achieved, which would require a dramatic swing from the current -$0.03 trailing EPS.
The biggest risks are the potential for continued losses, competitive pressure from larger rivals, and the stock's high beta of 2.381. This Hold would upgrade to Buy if the company demonstrates two consecutive quarters of positive operating cash flow and revenue growth accelerates above 20%, or if the stock pulls back to the $48-$50 range (near the 52-week low) providing a better risk/reward. It would downgrade to Sell if gross margins fall below 55% or if revenue growth decelerates below 10%. Relative to its history, the stock is near the low end of its PS range, suggesting it is fairly valued to slightly undervalued on a sales basis, but the lack of earnings makes it difficult to call it cheap.
Sign up to view all
AMBA 12-Month Price Forecast
Ambarella presents a balanced risk/reward at current levels. The company is making progress on profitability with narrowing losses and stable gross margins, and the balance sheet is strong. However, the valuation remains rich at 7x sales for a 13% grower, and the stock has significantly underperformed the market. The edge AI narrative is compelling but unproven, and the wide analyst target range reflects this uncertainty. I would upgrade to bullish if revenue growth accelerates above 20% and operating cash flow turns positive, or downgrade to bearish if gross margins fall below 55% or revenue growth stalls.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ambarella Inc.'s 12-month outlook, with a consensus price target around $87.55 and implied upside of +31.6% versus the current price.
Average Target
$87.55
0 analysts
Implied Upside
+31.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $120
Analyst target range
Coverage is solid for a company of this size, with 11 analysts and an average target price of $89.36, implying roughly +44.8% upside from the current $61.70. The recommendation field is listed as "none," but the institutional ratings history shows a clearly bullish tilt: Rosenblatt, Stifel, and Susquehanna carry Buy/Positive ratings, while B of A Securities and Roth Capital sit at Neutral, and there have been no downgrades in the recent tape, with Rosenblatt reiterating Buy as recently as September 16, 2026. The consensus therefore leans bullish, with the average target well above the current price and even the low end above where the stock trades.
The target range of $65.00 to $120.00 is wide, spanning roughly 85% from low to high, which signals meaningful disagreement about the pace of the edge AI ramp and profitability timeline. The $120 high target, highlighted in recent coverage as a major vote of confidence, assumes successful automotive and edge AI design-win conversion, multiple expansion, and a credible path to profitability, while the $65 low target is only about 5% above the current price and effectively prices in continued losses, margin pressure, and no re-rating. Consensus FY revenue estimates of $940 million and EPS of $4.35 imply a dramatic step-up from current run-rate levels, so the bull case depends heavily on estimate delivery; the wide spread and the stock's 2.38 beta mean investors should expect large swings around earnings and treat the average target as a directional signal rather than a precise price objective.
Bulls vs Bears: AMBA Investment Factors
The bear case currently has stronger evidence: the company remains unprofitable with negative free cash flow, trades at a premium 7x sales multiple, and has severely underperformed the market with a 2.38 beta. However, the bull case is not without merit—losses are narrowing sharply, the balance sheet is pristine, and analyst targets imply 44.8% upside. The single most important tension is whether the edge AI and automotive design-win pipeline can drive revenue growth acceleration and operating leverage before the valuation premium compresses further. Resolution of this debate likely hinges on the next few quarters of revenue growth and margin progression.
Bullish
- Analyst consensus implies 44.8% upside: The average target price of $89.36 across 11 analysts sits 44.8% above the current $61.70, and even the low target of $65.00 is above the market price. Rosenblatt, Stifel, and Susquehanna carry Buy/Positive ratings with no recent downgrades, and a $120 high target signals conviction in the edge AI story.
- Losses narrowing sharply quarter-over-quarter: Q2 FY2027 net loss improved to -$6.69 million from -$18.09 million in Q1 and -$20.0 million a year ago, while operating margin improved from -18.1% to -7.5%. Gross margin held at 57.7%, demonstrating pricing power and a clear path toward breakeven if revenue scales.
- Fortress balance sheet with negligible debt: Debt-to-equity is just 0.0226 and the current ratio is 2.31, with $102.3 million in cash. This provides ample runway to fund the edge AI and automotive roadmap without dilution or solvency risk, a key differentiator for a pre-profit semiconductor company.
- Revenue growth accelerating from small base: Q2 revenue of $108.1 million grew 13.2% year-over-year, and the trailing four quarters show a steady climb from $85.9 million to $100.4 million, $100.9 million, and $108.1 million. This sequential progression suggests design wins are converting to revenue incrementally rather than in one lump.
Bearish
- Still unprofitable with negative free cash flow: Trailing net margin is -19.4% and Q2 free cash flow was -$7.08 million, with TTM FCF of only $9.08 million against a $2.73 billion market cap (0.3% FCF yield). Heavy stock-based compensation of $22.7 million in Q2 alone dilutes shareholders and raises quality-of-earnings concerns.
- Premium valuation on unproven profitability: At 7.0x PS and 6.07x EV/Sales, the stock trades at a premium to semiconductor peers despite 13.2% growth and negative margins. The forward PE of 55.06x relies on consensus EPS of $4.35, a dramatic swing from the current -$0.03 trailing EPS, leaving little room for execution error.
- Severe relative underperformance and high volatility: The stock is down 26.6% over the past year versus the S&P 500's +15.5%, a relative strength of -42.2. Beta of 2.381 means it is more than twice as volatile as the market, and the max drawdown of -49.06% illustrates the punishing swings for holders.
- Failed breakouts signal supply overhead: The stock repeatedly spiked to $93.57 in late May and $88.34 in early July but faded back to $61.70, showing a lack of sustained buying conviction. The $85-$90 zone has become a ceiling, and a breakdown below $60 would confirm the longer-term downtrend.
AMBA Technical Analysis
Ambarella is in a choppy, range-bound consolidation rather than a clean trend, with the stock down 26.63% over the past year and sitting at $61.70 against a 52-week range of $48.30 to $96.69, which places it at roughly 27.7% of that range, or about 72% below its 52-week high. That positioning near the lower third of the annual range signals a stock that has lost momentum and is closer to value-territory than momentum-territory, though the repeated failure to hold rallies argues against calling it a clean falling knife. The 6-month change of +5.96% versus the 1-year decline of -26.63% shows the stock has stabilized off its lows but has not recovered meaningfully, and the YTD decline of -17.91% versus the S&P 500's +11.93% underscores severe relative weakness.
Short-term momentum is soft and slightly negative: the 1-month change is -1.70% and the 3-month change is -0.23%, both trailing the S&P 500's +1.22% and +2.69% over the same windows, producing relative strength readings of -2.92 and -2.92 respectively. The 1-month and 3-month figures are essentially flat, which diverges from the much steeper 1-year decline and suggests the downtrend has decelerated into a sideways base rather than accelerating lower. The most recent session showed a -2.60% drop to $61.70 on volume of about 2.03 million shares, and the stock has repeatedly spiked toward the mid-$80s (including a run to $93.57 in late May and $88.34 in early July) only to fade back, a pattern of failed breakouts that signals supply overhead and a lack of sustained buying conviction.
Key technical support sits at the 52-week low of $48.30, roughly 22% below the current price, while resistance is anchored at the 52-week high of $96.69, about 57% above current levels; the more immediate battleground is the $85-$90 zone where multiple rallies have stalled. A decisive breakout above that band would signal a genuine trend reversal and likely require a fundamental catalyst, whereas a breakdown below $60 and then the $48.30 low would confirm the longer-term downtrend and open deeper downside. With a beta of 2.381, Ambarella is more than twice as volatile as the market, meaning its swings are amplified and position sizing must account for roughly 2.4x market risk; the maximum drawdown of -49.06% over the period illustrates how punishing that volatility can be for holders.
Beta
2.38
2.38x market volatility
Max Drawdown
-49.1%
Largest decline past year
52-Week Range
$48-$97
Price range past year
Annual Return
-20.3%
Cumulative gain past year
| Period | AMBA Return | S&P 500 |
|---|---|---|
| 1m | -1.7% | -1.0% |
| 3m | -2.3% | +2.9% |
| 6m | -0.6% | +6.5% |
| 1y | -20.3% | +13.1% |
| ytd | -11.5% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMBA Fundamental Analysis
Revenue is growing at a solid clip but from a small base: Q2 FY2027 revenue was $108.1 million, up 13.21% year over year from $95.5 million in the year-ago quarter, and the trailing four quarters show a clear upward trajectory from $85.9 million in Q1 FY2026 to $100.4 million, $100.9 million, and $108.1 million in the most recent periods. Gross profit rose to $62.4 million from $55.0 million a year earlier, confirming that growth is flowing through at healthy unit economics, and the sequential revenue progression suggests the edge AI and automotive ramps are contributing incrementally rather than in one lump. The 13.2% growth rate is respectable for a company of this size but not explosive, implying the investment case rests more on the durability and eventual margin leverage of the edge AI transition than on near-term hypergrowth.
Ambarella remains unprofitable on a GAAP basis, with Q2 net income of -$6.69 million (a -6.19% net margin) and a -$0.15 diluted EPS, though this is a marked improvement from -$18.1 million in Q1 FY2027 and -$20.0 million in the year-ago Q2. Gross margin is stable and strong at 57.73%, consistent with the 57.7%-59.1% band maintained over the past several quarters, which is healthy for a fabless semiconductor designer and indicates pricing power is intact. The drag is operating expense, particularly R&D at $50.6 million (roughly 47% of revenue) plus $19.98 million in SG&A, producing an operating margin of -7.53%; the loss is narrowing sharply quarter over quarter, but the company still spends heavily to defend its technology lead, and reaching sustained profitability will require either revenue scale or expense discipline.
The balance sheet is a fortress: debt-to-equity is just 0.0226, the current ratio is 2.31, and cash stood at $102.3 million at the end of Q2, so there is essentially no solvency risk and ample liquidity to fund the roadmap. Cash generation, however, is lumpy and currently weak: Q2 operating cash flow was -$0.26 million and free cash flow was -$7.08 million, following a much stronger Q1 with -$25.6 million operating cash flow, while trailing-twelve-month free cash flow is a modest $9.08 million against a $2.73 billion market cap, a negligible FCF yield. Returns are negative (ROE -12.75%, ROA -5.23%), and heavy stock-based compensation ($22.7 million in Q2 alone) is a real dilution and quality-of-earnings concern, meaning the company is not yet self-funding growth at a level that would satisfy profitability-focused investors.
Quarterly Revenue
$108125000.0B
2026-07
Revenue YoY Growth
+13.2%
YoY Comparison
Gross Margin
57.7%
Latest Quarter
Free Cash Flow
$9080000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMBA Overvalued?
Because Ambarella's trailing net income is negative (EPS of -$0.028 and a trailing PE of -35.98), the PE ratio is not meaningful, so the appropriate primary metric is the price-to-sales ratio of 7.00x, supported by an EV/Sales of 6.07x. The forward PE of 55.06x on consensus FY estimates implies the market expects a dramatic swing to profitability, and the gap between the negative trailing PE and the positive 55x forward multiple captures the entire bull case: investors are paying today for earnings that do not yet exist, which leaves little room for execution error.
Against semiconductor industry norms, a 7.0x PS multiple is a clear premium for a company growing revenue only 13.2% with negative net margins, though it is less extreme than the 35.0x PS the stock commanded in Q2 FY2027 on a different share-price basis in the historical data. The premium is defensible only if one believes the edge AI and automotive design-win pipeline will drive both faster growth and operating leverage; the PEG ratio of 0.96 is the one metric that looks reasonable, but it relies on forward estimates that assume a sharp earnings inflection. On EV/EBITDA of -53.2x, the company is uninvestable on traditional cash-earnings metrics, reinforcing that this is a growth-and-story valuation rather than a value one.
Historically, Ambarella's PS ratio has ranged widely, from roughly 23.6x in Q1 FY2026 to 53.4x in Q2 FY2024, with the current 7.0x sitting near the low end of that band on the provided current-price basis, which could suggest either a value opportunity or a de-rating reflecting slower growth and persistent losses. The price-to-book ratio of 4.60x is moderate relative to the 6.1x seen in Q2 FY2027, and the stock's -26.6% one-year decline has compressed multiples meaningfully. The market is no longer pricing in blue-sky optimism, but at 7x sales with negative margins, it is still pricing in a successful turnaround rather than a cheap asset.
PE
-36.0x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-53.2x
Enterprise Value Multiple
Investment Risk Disclosure
Ambarella's financial risk is dominated by its lack of profitability and cash generation. Trailing net margin is -19.4% and Q2 free cash flow was -$7.08 million, with TTM FCF of only $9.08 million against a $2.73 billion market cap, a negligible 0.3% FCF yield. R&D spending at $50.6 million (47% of revenue) and SG&A of $20.0 million keep operating margins negative at -7.5%, and heavy stock-based compensation of $22.7 million in Q2 alone dilutes shareholders by roughly 1.5% per quarter. While the balance sheet is strong with debt-to-equity of 0.0226 and $102.3 million in cash, the company is not yet self-funding growth, and sustained losses could force a capital raise or strategic pivot.
Market and competitive risks are amplified by the stock's high beta of 2.381, meaning it is more than twice as volatile as the market and vulnerable to sharp selloffs during risk-off periods. The valuation at 7.0x PS and 55x forward PE leaves little room for disappointment; any slowdown in design-win momentum or delay in automotive ramps could trigger multiple compression. Competition from larger rivals like Qualcomm, NVIDIA, and Mobileye in edge AI and automotive vision is intense, and Ambarella's niche focus may limit its pricing power over time. Recent news highlights a $120 price target and Q2 beats, but the stock's 26.6% one-year decline and -42.2 relative strength versus the S&P 500 suggest the market remains skeptical of the growth story.
The worst-case scenario would involve a combination of revenue growth decelerating below 10%, gross margins slipping below 55%, and a broader semiconductor sector de-rating. In that scenario, the stock could retest its 52-week low of $48.30, representing a 22% decline from the current $61.70. A more severe outcome, such as a major design-win loss or a failed automotive ramp, could push the stock toward the analyst low target of $65 (which is actually above the current price) or lower, with historical max drawdown of -49.06% suggesting a potential drop to the low $30s in a prolonged bear market. Investors should be prepared for a 20-50% drawdown given the stock's volatility and unprofitable status.
FAQ
The key risks are: 1) Financial risk: continued unprofitability with -19.4% net margin and negative free cash flow, plus heavy stock-based compensation diluting shareholders. 2) Competitive risk: larger rivals like Qualcomm and NVIDIA could pressure pricing and limit design wins. 3) Macro risk: high beta of 2.381 makes the stock vulnerable to market downturns and sector rotation. 4) Company-specific risk: dependence on the edge AI and automotive ramp, with a wide analyst target range ($65-$120) reflecting uncertainty. The most severe risk is a revenue growth slowdown that would compress the premium valuation.
Our 12-month forecast has three scenarios: Bull (25% probability) targeting $100-$120, Base (50%) targeting $75-$90, and Bear (25%) targeting $48-$65. The base case is most likely, assuming revenue growth in the mid-teens and gradual margin improvement, leading the stock toward the analyst average target of $89.36. The key assumption is that the company meets consensus revenue estimates of $940 million and EPS of $4.35, which would require a significant acceleration from current levels. The wide range reflects the uncertainty around the edge AI ramp and profitability timeline.
AMBA appears overvalued on traditional metrics but fairly valued on a growth-adjusted basis. The trailing PE is negative, and the forward PE of 55.06x is high, but the PS ratio of 7.0x is near the low end of its historical range (23.6x to 53.4x). The PEG ratio of 0.96 suggests the valuation is reasonable if forward EPS estimates of $4.35 are met, but that requires a dramatic swing to profitability. Compared to semiconductor peers, the premium is justified only if the company can accelerate growth and expand margins. The market is pricing in a successful turnaround, leaving little room for error.
From a risk/reward perspective, AMBA is a speculative buy at current levels for aggressive investors. The stock trades at $61.70, implying 44.8% upside to the average analyst target of $89.36, and the low target of $65 is still above the current price. However, the company is unprofitable with a -19.4% net margin and negative free cash flow, and the 7x PS multiple is rich for a 13.2% grower. The biggest downside risk is a retest of the 52-week low of $48.30, representing a 22% decline. Therefore, it is a good buy only for those with a high risk tolerance and a long-term horizon who believe in the edge AI story, preferably accumulating on dips toward $50-$55.
AMBA is more suitable for long-term investment (minimum 2-3 years) given its early-stage growth story and high volatility. The company is investing heavily in R&D to capture the edge AI opportunity, and profitability is likely several quarters away. Short-term trading is risky due to the beta of 2.381 and the stock's history of failed breakouts. A long-term horizon allows time for design wins to convert to revenue and for operating leverage to materialize. Investors should be prepared for significant drawdowns, as evidenced by the -49.06% max drawdown, and consider position sizing accordingly.